Senseonics Holdings, Inc. (SENS)
About Senseonics Holdings, Inc.
Senseonics Holdings Inc is a medical technology company focused on the development and commercialization of a long-term, implantable continuous glucose monitoring (CGM) system to improve the lives of people with diabetes by enhancing their ability to manage their disease with relative ease and accuracy. Its implantable CGM system, Eversense, including Eversense E3 and Eversense 365 CGM systems, measures glucose levels via an under-the-skin sensor, a removable and rechargeable smart transmitter, and an app for real-time diabetes monitoring and management. The company operates through one reportable segment which derives its revenues from diabetes products and services and generates the majority of its revenue from the United States.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Revenue FY2025
- $35.3M
- Net income
- -$69.1M
- Total assets
- $126.3M
- Market cap
- $348.2M
- Gross margin
- 44.7%
- Operating margin
- -193.8%
- Net margin
- -196.0%
Source: SEC EDGAR · updated Jun 7, 2026
Revenue & profit trend
Financial statements
Income statement
- Revenue
- $35.3M
- Cost of revenue
- $19.5M
- Gross profit
- $15.8M
- Operating expenses
- $84.1M
- Operating income
- -$68.3M
- Income tax
- $0
- Net income
- -$69.1M
- EPS (basic)
- $-1.66
- EPS (diluted)
- $-1.66
Balance sheet
- Total assets
- $126.3M
- Current assets
- $117.5M
- Total liabilities
- $65.2M
- Current liabilities
- $24.3M
- Shareholders’ equity
- $61.0M
Cash flow
- Operating cash flow
- -$59.1M
- Investing cash flow
- -$53.4M
- Financing cash flow
- $78.2M
- Net cash flow
- -$34.4M
Statements via Polygon.io (SEC filings)
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Market cap
- $348.2M
- EPS (diluted)
- $-1.66
- Shares outstanding
- 71.6M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Mar 18, 2016
Senseonics Holdings, Inc. (SENS) Stock Price
- Reported a net loss of $69.1M in FY2025.
- Revenue grew 158% from FY2021 to FY2025.
- Gross margin of 44.7%, net margin -196.0%.
- Trading 58% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review Senseonics Holdings, Inc..
Write a review
News about Senseonics Holdings, Inc.
News & sentiment via Polygon.io
Senseonics Holdings, Inc.: frequently asked questions
Is Senseonics Holdings, Inc. an American company?
Senseonics Holdings, Inc. is a US-based company headquartered in Germantown, Maryland, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Where is Senseonics Holdings, Inc. headquartered?
Senseonics Holdings, Inc. is headquartered in Germantown, Maryland, United States.
Is Senseonics Holdings, Inc. publicly traded?
Yes — Senseonics Holdings, Inc. is a publicly traded company. Its stock trades under the ticker symbol SENS on the NASDAQ.
What does Senseonics Holdings, Inc. do?
Senseonics Holdings, Inc. is an American Medical Devices company in the Health & Beauty sector.
